Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANI PHARMACEUTICALS INC Director's Dealing 2013

Aug 22, 2013

31676_dirs_2013-08-22_449073ee-3835-4e32-b1d9-976e50a703e4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2013-08-20

Reporting Person: MANGANO ROSS J (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-08-20 Common stock, par value $0.0001 per share P 10000 $7.4659 Acquired 18550 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common stock, par value $0.0001 per share 50957 Indirect
Common stock, par value $0.0001 per share 833 Indirect
Common stock, par value $0.0001 per share 4604 Direct

Footnotes

F1: Held by various trusts, of which the Reporting Person is the trustee, for the benefit of family members.

F2: Held by JO & Co., of which the Reporting Person is a partner.

F3: Held by Oliver & Co., of which the Reporting Person is the trustee.